Management congenital heart disease surgery during COVID-19: a review article

Congenital heart disease is a form of heart abnormality that has been acquired since the newborn. The clinical course of this disorder varies from mild to severe. In mild forms, there are often no symptoms, and no abnormalities are found on clinical examination. Whereas in severe CHD, symptoms have...

Full description

Saved in:
Bibliographic Details
Main Authors: Gofur, Nanda Rachmad Putra, Gofur, Aisyah Rachmadani Putri, Soesilaningtyas, ., Gofur, Rizki Nur Rachman Putra, Kahdina, Mega, Putri, Hernalia Martadila, Mohd Yusof, Zamros Yuzadi
Format: Article
Published: University of Dicle 2022
Subjects:
Online Access:http://eprints.um.edu.my/43467/
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128852608&partnerID=40&md5=3fc4708fe84d62158177922dcd103a66
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.43467
record_format eprints
spelling my.um.eprints.434672023-10-31T03:57:40Z http://eprints.um.edu.my/43467/ Management congenital heart disease surgery during COVID-19: a review article Gofur, Nanda Rachmad Putra Gofur, Aisyah Rachmadani Putri Soesilaningtyas, . Gofur, Rizki Nur Rachman Putra Kahdina, Mega Putri, Hernalia Martadila Mohd Yusof, Zamros Yuzadi RK Dentistry Congenital heart disease is a form of heart abnormality that has been acquired since the newborn. The clinical course of this disorder varies from mild to severe. In mild forms, there are often no symptoms, and no abnormalities are found on clinical examination. Whereas in severe CHD, symptoms have been visible since birth and require immediate action. Generally, the management of congenital heart disease includes non-surgical management and surgical management. Non-surgical management includes medical management and interventional cardiology. Medical management is generally secondary as a result of complications from heart disease itself or due to other accompanying disorders. In this case, the goal of medical therapy is to relieve symptoms and signs in addition to preparing for surgery. The duration and method of administration of drugs depend on the type of disease at hand. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which led to the coronavirus disease 2019 (COVID-19) pandemic, was initially reported in Wuhan, China in December, 2019. The rapid rise in the number of cases worldwide led to hospitals struggling to cope with the sudden influx of patients. This has had a ripple effect on other parts of health care as manpower and supplies needed to be reallocated. Within cardiology, this has led to outpatient appointments and elective surgeries being reduced and/or postponed. COVID-19 appears to have a complicated relationship with cardiovascular system, as studies have suggested cardiovascular diseases increase disease severity and mortality rates in those who are infected. However, the virus has also been shown to cause cardiovascular complications such as acute myocardial injury, heart failure, and arrhythmia. Coronavirus may also cause myocardial injury via the cytokine storm that occurs in response to a possible large immune response during the infection. Cardiac involvement such as right ventricular failure and congestion can either be a result of respiratory distress or direct cardiac injury caused by the virus, as suggested by the raised cardiac troponin I in critical patients compared to non-critical patients. © 2022, Journal of International Dental and Medical Research. All Rights Reserved. University of Dicle 2022 Article PeerReviewed Gofur, Nanda Rachmad Putra and Gofur, Aisyah Rachmadani Putri and Soesilaningtyas, . and Gofur, Rizki Nur Rachman Putra and Kahdina, Mega and Putri, Hernalia Martadila and Mohd Yusof, Zamros Yuzadi (2022) Management congenital heart disease surgery during COVID-19: a review article. Journal of International Dental and Medical Research, 15 (1). pp. 344-348. ISSN 1309-100X, https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128852608&partnerID=40&md5=3fc4708fe84d62158177922dcd103a66
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic RK Dentistry
spellingShingle RK Dentistry
Gofur, Nanda Rachmad Putra
Gofur, Aisyah Rachmadani Putri
Soesilaningtyas, .
Gofur, Rizki Nur Rachman Putra
Kahdina, Mega
Putri, Hernalia Martadila
Mohd Yusof, Zamros Yuzadi
Management congenital heart disease surgery during COVID-19: a review article
description Congenital heart disease is a form of heart abnormality that has been acquired since the newborn. The clinical course of this disorder varies from mild to severe. In mild forms, there are often no symptoms, and no abnormalities are found on clinical examination. Whereas in severe CHD, symptoms have been visible since birth and require immediate action. Generally, the management of congenital heart disease includes non-surgical management and surgical management. Non-surgical management includes medical management and interventional cardiology. Medical management is generally secondary as a result of complications from heart disease itself or due to other accompanying disorders. In this case, the goal of medical therapy is to relieve symptoms and signs in addition to preparing for surgery. The duration and method of administration of drugs depend on the type of disease at hand. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which led to the coronavirus disease 2019 (COVID-19) pandemic, was initially reported in Wuhan, China in December, 2019. The rapid rise in the number of cases worldwide led to hospitals struggling to cope with the sudden influx of patients. This has had a ripple effect on other parts of health care as manpower and supplies needed to be reallocated. Within cardiology, this has led to outpatient appointments and elective surgeries being reduced and/or postponed. COVID-19 appears to have a complicated relationship with cardiovascular system, as studies have suggested cardiovascular diseases increase disease severity and mortality rates in those who are infected. However, the virus has also been shown to cause cardiovascular complications such as acute myocardial injury, heart failure, and arrhythmia. Coronavirus may also cause myocardial injury via the cytokine storm that occurs in response to a possible large immune response during the infection. Cardiac involvement such as right ventricular failure and congestion can either be a result of respiratory distress or direct cardiac injury caused by the virus, as suggested by the raised cardiac troponin I in critical patients compared to non-critical patients. © 2022, Journal of International Dental and Medical Research. All Rights Reserved.
format Article
author Gofur, Nanda Rachmad Putra
Gofur, Aisyah Rachmadani Putri
Soesilaningtyas, .
Gofur, Rizki Nur Rachman Putra
Kahdina, Mega
Putri, Hernalia Martadila
Mohd Yusof, Zamros Yuzadi
author_facet Gofur, Nanda Rachmad Putra
Gofur, Aisyah Rachmadani Putri
Soesilaningtyas, .
Gofur, Rizki Nur Rachman Putra
Kahdina, Mega
Putri, Hernalia Martadila
Mohd Yusof, Zamros Yuzadi
author_sort Gofur, Nanda Rachmad Putra
title Management congenital heart disease surgery during COVID-19: a review article
title_short Management congenital heart disease surgery during COVID-19: a review article
title_full Management congenital heart disease surgery during COVID-19: a review article
title_fullStr Management congenital heart disease surgery during COVID-19: a review article
title_full_unstemmed Management congenital heart disease surgery during COVID-19: a review article
title_sort management congenital heart disease surgery during covid-19: a review article
publisher University of Dicle
publishDate 2022
url http://eprints.um.edu.my/43467/
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128852608&partnerID=40&md5=3fc4708fe84d62158177922dcd103a66
_version_ 1781704706826960896
score 13.211869